Clinical Trial Update: Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study comparing dose-dense docetaxel given before versus after standard doxorubicin/cyclophosphamide in axillary node-positive breast cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED